Marketing of Clozaril :
improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991.

Description

Tools

Cite this Export citation file
Corporate Author
United States. Congress.
Language(s)
English
Published
Washington : U.S. G.P.O. : 1991.
Subjects
Sandoz Pharmaceuticals Corporation
Sandoz Pharmaceuticals Corporation.
Medical care > Cost control
Drugs > Prices
Medical care > United States > Cost control.
Drugs > Prices > United States.
Clozapine > Marketing.
United States
Note
"Serial no. J-102-6."
Physical Description
iii, 139 p. ; 24 cm.
ISBN
0160354927
Locate a Print Version
Find in a library

Viewability

Item Link Original Source
Full view   Cornell University
Full view   Purdue University
Full view   4.J 89/2:S.hrg.102-175 Pennsylvania State University